Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity) (SARSCoV2CZImun)
Sponsor: Brno University Hospital
Listed as NCT04453280, this observational or N/A phase trial focuses on COVID and SARS-CoV-2 and remains completed. Sponsored by Brno University Hospital, it has been updated 7 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
-
Jan 2021 — Oct 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Aug 2020 — Nov 2020 [monthly]
Completed
First recorded
May 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brno University Hospital
- Institute for Clinical and Experimental Medicine
- Institute of Health Information and Statistics of the Czech Republic
- Masaryk Memorial Cancer Institute
- Masaryk University
- Ministry of Health, Czech Republic
- Public Health Office of the Capital City of Prague, Czech Republic
- Regional Public Health Office of the Central Bohemian Region based in Prague, Czech Republic
- Regional Public Health Office of the South Moravian Region based in Brno, Czech Republic
- St. Anne's University Hospital Brno, Czech Republic
For direct contact, visit the study record on ClinicalTrials.gov .